FDAClass IIIJanuary 29, 2025

Venlafaxine Extended-Release Tablets recall

Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.

Why was Venlafaxine Extended-Release Tablets recalled?

Failed Tablet/Capsule Specifications: Missing tab ID on either side of the tablet

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot #: 2402101UR, Exp 02/28/2027

Product
Venlafaxine Extended-Release Tablets, 150mg, Rx only, 90 Tablets, Manufactured by Appco Pharma. LLC, NDC 43598-943-90.
Recalling firm
Appco Pharma LLC
Quantity
1380 bottles
Distribution
Nationwide USA.
Recall date
January 29, 2025
Classification
Class III
Status
Completed
Agency
FDA (drug)
Open FDA enforcement record Latest recalls